Yu Wengui, Kavi Tapan, Majic Tamara, Alva Kimberly, Moheet Asma, Lyden Patrick, Schievink Wouter, Lekovic Gregory, Alexander Michael
Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Front Neurol. 2018 Mar 15;9:152. doi: 10.3389/fneur.2018.00152. eCollection 2018.
Aneurysmal subarachnoid hemorrhage (aSAH) is the most severe type of stroke. In 2012, the Joint Commission, in collaboration with the American Heart Association/American Stroke Association (AHA/ASA), launched the Advanced Certification for Comprehensive Stroke Centers (CSCs). This new level of certification was designed to promote higher standard of care for patients with complex stroke.
The goal of this study was to examine the treatment modality and quality benchmarks of aSAH at one of the first five certified CSCs in the United States.
Consecutive patients with aSAH at Cedars-Sinai Medical Center between April 1, 2012 and May 30, 2014 were included for this retrospective study. The ruptured aneurysm was treated with coiling or clipping within 24 h. All patients were managed per AHA guidelines. Discharge outcomes were assessed using modified Rankin Scale (mRS). The rate of aneurysm treatment, door-to-treatment time, rate of posttreatment rebleed, hospital length of stay (LOS), discharge outcome, and mortality rates were evaluated as quality indicators.
The median age (interquartile range) of the 118 patients with aSAH was 55 (19). Among them, 84 (71.2%) were females, 94 (79.7%) were transfers from outside hospitals, and 74 (62.7%) had Hunt and Hess grades 1-3. Sixty patients (50.8%) were treated with coiling, 52 (44.1%) with clipping, and 6 (5.1%) untreated due to ictal cardiac arrest or severe comorbidities. The rate of aneurysm treatment was 95% (112/118) with median door-to-treatment time at 12.5 (8.5) h and 0.9% (1/112) posttreatment rebleed. The median ICU and hospital LOS were 12.5 (7) and 17.0 (14.5) days, respectively. Coiling was associated with significantly shorter LOS than clipping. There were 59 patients (50%) with favorable outcome and 19 deaths (16.1%) at hospital discharge. There was no significant difference in discharge outcome between coiling and clipping.
Care of aSAH at one of the early CSCs in the United States was associated with high rate of aneurysm treatment, fast door-to-treatment time, low posttreatment rebleed, excellent outcome, and low mortality rate. Coiling was associated with significant shorter LOS than clipping. There was no significant difference in discharge outcomes between treatment modalities.
动脉瘤性蛛网膜下腔出血(aSAH)是最严重的卒中类型。2012年,联合委员会与美国心脏协会/美国卒中协会(AHA/ASA)合作,推出了综合卒中中心(CSCs)高级认证。这一新的认证级别旨在促进对复杂卒中患者的更高护理标准。
本研究的目的是在美国首批五个获得认证的CSCs之一,研究aSAH的治疗方式和质量基准。
纳入2012年4月1日至2014年5月30日在雪松西奈医疗中心连续收治的aSAH患者进行这项回顾性研究。破裂动脉瘤在24小时内进行栓塞或夹闭治疗。所有患者均按照AHA指南进行管理。出院时使用改良Rankin量表(mRS)评估结局。将动脉瘤治疗率、入院至治疗时间、治疗后再出血率、住院时间(LOS)、出院结局和死亡率作为质量指标进行评估。
118例aSAH患者的中位年龄(四分位间距)为55岁(19岁)。其中,84例(71.2%)为女性,94例(79.7%)从外院转入,74例(62.7%)Hunt和Hess分级为1 - 3级。60例(50.8%)接受栓塞治疗,52例(44.1%)接受夹闭治疗,6例(5.1%)因癫痫发作时心脏骤停或严重合并症未治疗。动脉瘤治疗率为95%(112/118),中位入院至治疗时间为12.5(8.5)小时,治疗后再出血率为0.9%(1/112)。ICU和住院中位LOS分别为12.5(7)天和17.0(14.5)天。栓塞治疗后的LOS明显短于夹闭治疗。59例(50%)患者出院时预后良好,19例死亡(16.1%)。栓塞和夹闭治疗在出院结局方面无显著差异。
美国早期CSCs之一对aSAH的护理与高动脉瘤治疗率、快速入院至治疗时间、低治疗后再出血率、良好结局和低死亡率相关。栓塞治疗后的LOS明显短于夹闭治疗。不同治疗方式在出院结局方面无显著差异。